BBBT (Black Bird Biotech) EBITDA Margin %: 1,050.00% (As of Sep. 2023)

What is Black Bird Biotech EBITDA Margin %?

Black Bird Biotech BBBT -99.00% EBITDA Margin % is 1,050.00% as of Sep. 2023.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Black Bird Biotech's EBITDA for the three months ended in Sep. 2023 was $0.04 Mil. Black Bird Biotech's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Black Bird Biotech's EBITDA margin for the quarter that ended in Sep. 2023 was 1,050.00%.

Black Bird Biotech (OTCPK:BBBT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Black Bird Biotech EBITDA Margin % Related Terms

Black Bird Biotech EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Black Bird Biotech's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Black Bird Biotech EBITDA Margin % Chart

Black Bird Biotech Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBITDA Margin %

Get a 7-Day Free Trial

0.00

-1,179.31

-1,361.54

-1,444.58

Black Bird Biotech Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
EBITDA Margin %	Get a 7-Day Free Trial															-600.00	-1,041.67	1,085.71	-138.46	1,050.00

BBBT vs BLMS, INLB, CENBF: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Black Bird Biotech's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Black Bird Biotech EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Black Bird Biotech's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Black Bird Biotech's EBITDA Margin % falls into.

Save Embed

Black Bird Biotech EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Black Bird Biotech's EBITDA Margin % for the fiscal year that ended in Dec. 2022 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-1.199	/	0.083
	=	-1,444.58 %

Black Bird Biotech's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	0.042	/	0.004
	=	1,050.00 %

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of 1,050.00% mean?

Black Bird Biotech (BBBT) has a EBITDA Margin % of 1,050.00% as of Sep. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Black Bird Biotech and its competitors.

Is Black Bird Biotech's EBITDA Margin % too high?

Black Bird Biotech's current EBITDA Margin % is 1,050.00%. The Drug Manufacturers industry median EBITDA Margin % is 12.54. Black Bird Biotech's value of 1,050.00% is 8273.2% above this industry median.

How does Black Bird Biotech's EBITDA Margin % compare to BLMS and INLB?

Black Bird Biotech's EBITDA Margin % of 1,050.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.54. Black Bird Biotech's value of 1,050.00% is 8273.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Drug Manufacturers company?

The median EBITDA Margin % among Drug Manufacturers companies is 12.54, based on 953 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Black Bird Biotech's current EBITDA Margin % of 1,050.00% is 8273.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Black Bird Biotech and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Black Bird Biotech's current EBITDA Margin % is 1,050.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Black Bird Biotech stock overvalued right now?

Black Bird Biotech (BBBT) has a current EBITDA Margin % of 1,050.00%. The current EBITDA Margin % is 1,050.00% and 8273.2% above the Drug Manufacturers industry median of 12.54. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Black Bird Biotech (BBBT), the current EBITDA Margin % is 1,050.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Black Bird Biotech Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies BLMS INLB CENBF DKSC ENDPQ PHBI DVLP HCANF BSPK SKYI ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX

Address 2801 E Camelback Road, Suite 200, Phoenix, AZ, USA, 85016

Website https://www.blackbirdpotentials.com

Black Bird Biotech Inc is a licensed grower of industrial hemp under the Montana Hemp Pilot Program. In addition, it is the distributor in the U. S. and Canada for MiteXstream, an EPA-registered plant-based biopesticide effective in the eradication of spider mites, a pest that destroys crops, especially cannabis, hops, coffee, and house plants, as well as molds and mildew. Its products include MiteXstream Biopesticide, Grizzly Creek Naturals, and Black Bird American Hemp.